Spruce Biosciences (NASDAQ: SPRB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Spruce Biosciences (NASDAQ: SPRB) through any online brokerage.
The latest price target for Spruce Biosciences (NASDAQ: SPRB) was reported by SVB Leerink on Wednesday, March 16, 2022. The analyst firm set a price target for 3.00 expecting SPRB to rise to within 12 months (a possible 80.72% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $1.66 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.